Goa's State-Owned Pharma Firm to be Taken Over by HLL

Goa Antibiotics and Pharmaceuticals Ltd.(GAPL) is now being taken over by the pharma business of the state capital-based HLL Lifecare Limited (HLL), a mini-ratna public sector enterprise of the ministry of health and family welfare, the company acquiring 74 percent equity.

Under the agreement, HLL proposes to expand this facility for diversifying its pharma portfolio. HLL would be retaining all the existing 205 employees of GAPL.

Fishing In Troubled Waters
Pharmaceutical drugs may be capable of effects that no one can ever dream of. Therefore it is important to set limits to the measure of drugs that man and animals could be exposed to.

"The acquisition of majority stake in GAPL shows HLL's intent and seriousness to expand its footprints in the country's booming pharma sector in a substantial manner," said M. Ayyappan, CMD of the company.

"HLL wishes to strengthen its pharma segment through similar acquisitions. It is also in tune with our diversification plans across the health segment," he said.

HLL has already made its presence felt in the pharma industry by offering a basket of women's healthcare products.

India to Figure Among the Top 10 in the Drugs and Pharmaceuticals With Health Insurance
Health care industry is on the brink of a massive growth according to a study by IMS.

It has a strong distribution network, reaching out to over 30,000 medical professionals and over 3,500 hospitals in the country.

Through its retail medicine networks in AIIMS, New Delhi, and Haryana, HLL provides 147 generic medicines.

Costs of Household Products, Pharmaceuticals Could be Cut by New Device
Nanoscale packages could actually result in huge cost savings.

HLL has set up a state-of-the-art hormonal formulation plant in Belgaum, Karnataka. It also has pharma production facilities in Belgaum and Indore.

The Goa cabinet, chaired by Chief Minister Manohar Parrikar, Wednesday had approved a proposal to disinvest 74 per cent equity stake of the state-owned GAPL in favour of HLL.

FDA Approves Aegerion Pharmaceuticals� Drug for a Cholesterol Disorder
Aegerion Pharmaceuticals' have come out with a novel drug used to treat a rare disease that causes extremely high levels of bad cholesterol. This drug has now received the nod by FDA.

Source-IANS